Highlights
TSX: VRX       Valeant Pharmaceuticals Intl Inc
Last Price Today's Change   Day's Range   Trading Volume
26.92   0.00 (0.00%)  0.00 - 0.00  0

Overview

 
Avg Volume (4 weeks):3,061,252
4 Weeks Range:17.73 - 29.28
4 Weeks Price Volatility (%):
91.94%
52 Weeks Range:13.10 - 29.28
52 Weeks Price Volatility (%):
91.94%
Average Price Target: 70.00
Price Target Upside/Downside: +43.08

Headlines



No recent Headlines for this stock.


Business Background

Valeant Pharmaceuticals International, Inc. is a pharmaceutical and medical device company. The Company is engaged in developing and marketing a range of branded, generic and branded generic pharmaceuticals, over-the-counter (OTC) products, and medical devices (contact lenses, intraocular lenses, ophthalmic surgical equipment, and aesthetics devices). It operates through two segments: Developed markets and Emerging markets. In the Developed Markets segment, it focuses on the areas of dermatology, neurology, gastrointestinal disorders, and eye health therapeutic classes. In the Emerging Markets segment, it focuses on primarily on branded generics, OTC products and medical devices. Its pharmaceutical products include Xifaxan, Solodyn and Glumetza. Its OTC products include PreserVision, Biotrue and Boston. Its other generic products include Latanoprost and Metronidazole. Its ophthalmic surgical products include intraocular lenses, such as Akreos, enVista, Crystalens and Trulign.

  Be the first to like this.
 


 

3860 

ActiveGainersLosers
Top 10 Active Counters
 NameLastChange 
 AAB 0.180.00 
 AAV 4.360.00 
 TD.PF.A 23.840.00 
 ABK.A 78.000.00 
 ABT 7.090.00 
 ABX 17.990.00 
 XHU 23.570.00 
 GXO 2.830.00 
 ACD 9.250.00 
 ACO.X 43.860.00 
Partners & Brokers